These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 4423376

  • 1. Aporphines. 11. Synthesis and dopaminergic acitivity of monohydroxyaporphines. Total synthesis of (plus, minus)-11-hydroxyaporphine, (plus and minus)-11-hydroxynoraporphine, and (plus, minus)-11-hydroxy-N-n-propylnoraporphine.
    Neumeyer JL, Granchelli FE.
    J Med Chem; 1974 Oct; 17(10):1090-5. PubMed ID: 4423376
    [No Abstract] [Full Text] [Related]

  • 2. Aporphines. 8. Total synthesis and pharmacological evaluation of (plus or minus)-apomorphine, (plus or minus)-apocodeine, (plus or minus)-N-n-propylnorapomorphine, and (plus or minus)-N-n-propylnorapocodeine.
    Neumeyer JL, Neustadt BR, Oh KH, Weinhardt KK, Boyce CB, Rosenberg FJ, Teiger DG.
    J Med Chem; 1973 Nov; 16(11):1223-8. PubMed ID: 4201182
    [No Abstract] [Full Text] [Related]

  • 3. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines.
    Costall B, Naylor RJ.
    J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preparation of 7-oxaaporphine derivatives and evaluation of their dopaminergic activity.
    Banzatti C, Carfagna N, Commisso R, Heidempergher F, Pegrassi L, Melloni P.
    J Med Chem; 1988 Jul; 31(7):1466-71. PubMed ID: 2968456
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines.
    Si YG, Choi YK, Gardner MP, Tarazi FI, Baldessarini RJ, Neumeyer JL.
    Bioorg Med Chem Lett; 2009 Jan 01; 19(1):51-3. PubMed ID: 19058967
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
    Miller RJ, Kelly PH, Neumeyer JL.
    Eur J Pharmacol; 1976 Jan 01; 35(1):77-83. PubMed ID: 943290
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. (R)-(-)-10-methyl-11-hydroxyaporphine: a highly selective serotonergic agonist.
    Cannon JG, Mohan P, Bojarski J, Long JP, Bhatnagar RK, Leonard PA, Flynn JR, Chatterjee TK.
    J Med Chem; 1988 Feb 01; 31(2):313-8. PubMed ID: 3339604
    [Abstract] [Full Text] [Related]

  • 14. Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
    Costall B, Naylor RJ, Neumeyer JL.
    Eur J Pharmacol; 1975 Mar 01; 31(1):1-16. PubMed ID: 1168579
    [Abstract] [Full Text] [Related]

  • 15. Further evidence for the stimulation of rat brain dopamine receptors by a cyclic analogue of dopamine.
    Woodruff GN, Elkhawad AO, Crossman AR, Walker RJ.
    J Pharm Pharmacol; 1974 Sep 01; 26(9):740-1. PubMed ID: 4155756
    [No Abstract] [Full Text] [Related]

  • 16. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ, Marsh ER, Kula NS, Zong RS, Gao YG, Neumeyer JL.
    Biochem Pharmacol; 1990 Aug 01; 40(3):417-23. PubMed ID: 2383279
    [Abstract] [Full Text] [Related]

  • 17. Proceedings: Effect of aporphine alkaloids on central dopamine receptors.
    Kelly PH, Miller RJ, Neumeyer JL.
    Br J Pharmacol; 1975 Jun 01; 54(2):271P. PubMed ID: 1148551
    [No Abstract] [Full Text] [Related]

  • 18. 5-HT1A-receptor antagonism: N-alkyl derivatives of (R)-(-)-8,11-dimethoxynoraporphine.
    Cannon JG, Jackson H, Long JP, Leonard P, Bhatnagar RK.
    J Med Chem; 1989 Aug 01; 32(8):1959-62. PubMed ID: 2569041
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?
    Creese I, Iversen SD.
    Psychopharmacol Bull; 1975 Oct 01; 11(4):12-3. PubMed ID: 1197588
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.